• 2015

Company Description

LIFNano Therapeutics specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor.

LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF)..